Most lately, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in related regions as classical opioid receptors, it binds into a wide array of endogenous opioids. In contrast to most opioid receptors, this receptor functions to be a scavenger and does not activate a second … Read More